Amylin Pharmaceuticals to Webcast First Quarter Results
April 19 2012 - 4:15PM
Business Wire
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will webcast its
Quarterly Update Conference Call for the first quarter of 2012 on
Thursday, April 26, 2012 at 8:30 a.m. ET/5:30 a.m. PT. Daniel M.
Bradbury, Amylin’s president and chief executive officer, will lead
the call. On the same date pre-market, Amylin will release
financial results for the first quarter of 2012.
The call will be webcast live through the “Investors” section of
Amylin's corporate website and a recording will be made available
following the close of the call. To access the webcast, please log
on to http://www.amylin.com approximately 15 minutes prior to the
call to register, download and install any necessary audio
software. For those without access to the Internet, the live call
may be accessed by phone by calling (888) 989-4344 (U.S./Canada) or
(312) 470-7140 (international), participant passcode number
7994841. A replay of the call will also be available by phone
beginning approximately two hours after the close of the call and
can be accessed at (800) 756-0205 (U.S./Canada) or (203) 369-3002
(international).
About Amylin PharmaceuticalsAmylin Pharmaceuticals is a
biopharmaceutical company dedicated to improving lives of patients
through the discovery, development and commercialization of
innovative medicines. Amylin is committed to delivering novel
therapies that transform the way diabetes and other metabolic
disorders are treated. Amylin is headquartered in San Diego, Calif.
and has a commercial manufacturing facility in Ohio. More
information on Amylin Pharmaceuticals is available at
www.amylin.com.
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Sep 2023 to Sep 2024